Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05675319
Title Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy (AlloRelapseMM)
Acronym AlloRelapseMM
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Universitatsklinikum Hamburg-Eppendorf
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.